Tonix Pharmaceuticals Holding Corp.
SKIN-BASED TESTING FOR DETECTION OF CELL-MEDIATED IMMUNE RESPONSES TO SARS-COV-2

Abstract:

The present disclosure provides methods for detecting cell-mediated immunity to SARS-CoV-2 in a subject, methods for detecting a cell-mediated immune response against SARS-CoV-2 in a subject and methods for determining if a vaccine against SARS-CoV-2 elicits a cell-mediated immune response in a subject, comprising administering to the skin of the subject one or more peptides.